Meeting
2011 Breast Cancer Symposium
Risk of having BRCA mutations in women with triple-negative breast cancer: A systematic review and meta-analysis.
Authors
N. M. Tun
The Brooklyn Hospital Center, Brooklyn, NY
N. M. Tun , G. M. Villani , K. Ong
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C
Track
Prevention, Survivorship & Health Policy
Sub Track
Genetics
Citation
J Clin Oncol 29, 2011 (suppl 27; abstr 160)
Abstract #
160
Poster Bd #
A10
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
The association of BRCA1 and BRCA2 mutations on prostate cancer risk, frequency, and mortality: Systematic review and meta-analysis.
First Author: Mok Oh
Poster
2014 ASCO Annual Meeting
Evaluation of BRCA1/2 mutation status among women with triple-negative breast cancer.
First Author: Axel Muendlein
Poster
2022 ASCO Annual Meeting
Predominance of BRCA2 mutation and estrogen receptor-positive breast cancer among BRCA1/2 mutation carriers.
First Author: Pascal Pujol
Poster
2018 Gastrointestinal Cancers Symposium
BRCA1 and BRCA2 gene mutations and colorectal cancer risk: Systematic review and meta-analysis.
First Author: Mok Oh